Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.54 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | DOT1L | Q8TEK3 | 2/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL291198 | 0.72 | TERT (0.67) | TERTDOT1LALOX15 | |
| Sulfuric Acid SCHEMBL8658789 | 0.67 | TERT (0.59) | TERTDOT1LALOX15 | |
| Iodide SCHEMBL9380644 | 0.67 | ROCK1 (0.52) | TERT | |
| Iodide SCHEMBL3500716 | 0.65 | NPC1 (0.49) | — | |
| Pyritidium SCHEMBL29387282 | 0.65 | MEN1 (0.49) | TERTDOT1LALOX15 | |
| Pyritidium SCHEMBL30468818 | 0.65 | MEN1 (0.51) | TERTDOT1LALOX15 | |
| Pyritidium SCHEMBL7636972 | 0.63 | MEN1 (0.49) | TERTDOT1LALOX15 | |
| SCHEMBL3500285 | 0.63 | CYP1A2 (0.47) | DHFR | |
| SCHEMBL3499609 | 0.62 | DNMT1 (0.36) | — | |
| Iodide SCHEMBL3498356 | 0.61 | DNMT1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312349-A1 | COMPOSITION AND METHODS OF TREATING INTRACELLULAR PATHOGEN INFECTION | UNIV HOSPITALS CLEVELAND MEDICAL CENTER (US) | 2025-10-09 | — | — | US | claimed |
| EP-4323054-A1 | CATHETERS INCLUDING METALLIC ALLOYS FOR INTRODUCTION OF THERAPEUTIC IONS | Rain Scientific, Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| WO-2022221287-A1 | CATHETERS INCLUDING METALLIC ALLOYS FOR INTRODUCTION OF THERAPEUTIC IONS | RAIN SCIENTIFIC, INC. (US) | 2022-10-20 | — | — | WO | claimed |
| US-20170291886-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | NEOCULI PTY LTD (AU) | 2017-10-12 | — | — | US | claimed |
| US-20090131342-A1 | Nitrosated and/or nitrosylated compounds, compositions and methods of use | NITROMED, INC. (US) | 2009-05-21 | — | — | US | claimed |
| EP-1718286-A2 | NITROSATED AND/OR NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2006-11-08 | — | — | EP | claimed |
| WO-2005070006-A2 | NITROSATED AND/OR NITROSYLATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2005-08-04 | — | — | WO | claimed |
| US-20030105066-A1 | Nitrate salts of antimicrobial agents | NICOX S.A. (FR) | 2003-06-05 | — | — | US | claimed |
| EP-1253924-A1 | NITRATE SALTS OF ANTIMICROBIAL AGENTS | NICOX S.A. (FR) | 2002-11-06 | — | — | EP | claimed |
| WO-2001054691-A1 | NITRATE SALTS OF ANTIMICROBIAL AGENTS | NICOX, S.A. (FR) | 2001-08-02 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0193414-A2 | Liposomes, process for their preparation and compositions containing them | Fluck, David John (ZW) | 1986-09-03 | — | — | EP | claimed |
| WO-2026110111-A1 | DIAZO COMPOUNDS WITH ANTI-TRYPANOSOMAL ACTIVITIES | INDIAN COUNCIL OF AGRICULTURAL RESEARCH (IN) | 2026-05-28 | — | — | WO | disclosed |
| EP-4094767-B1 | NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3448392-B1 | ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO | UNIV EMORY (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-0193414-A3 | LIPOSOMES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | Fluck, David John (ZW) | 1987-02-04 | — | — | EP | disclosed |
| EP-0193414-A2 | Liposomes, process for their preparation and compositions containing them | Fluck, David John (ZW) | 1986-09-03 | — | — | EP | disclosed |
| EP-0193414-A2 | Liposomes, process for their preparation and compositions containing them | Fluck, David John (ZW) | 1986-09-03 | — | — | EP | disclosed |
| US-4399151-A | USING A-SUBSTITUTERD AMINES OR A-SUBSTITUTED AMINO ACIDS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1983-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131342-A1 | Nitrosated and/or nitrosylated compounds, compositions and methods of use | LTC4S, LTB4R2, LTB4R | TERT 829/4885DHFR 1873/4885DOT1L 4721/4885 |
| US-20170291886-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | DPM1, ABCB11, PIGS | TERT 1265/4885DHFR 134/4885DOT1L 3772/4885 |
| US-20030105066-A1 | Nitrate salts of antimicrobial agents | NOS1, NOS3, NOS2 | TERT 4342/4885DHFR 1577/4885DOT1L 4640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.